Georges Gemayel files Form 144 to sell shares

Georges Gemayel filed a Form 144 reporting planned and recent sales of common stock.

Accepted by SEC EDGAR 03/06/2026 - 04:24 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Georges Gemayel filed a Form 144 reporting planned and recent sales of common stock. The filing lists a sale on 03/05/2026 of 10,000 shares for $537,117.00. It also shows securities to be sold from exercises: 3,787 shares by exercise on 03/06/2026 and 5,000 shares previously exercised on 03/04/2026.

The notice references an exercise under a registered plan and cash transactions; timing and cash‑flow recipients are described in the entries tied to those exercise dates.

Insights

Securities Compliance Analyst

Form 144 lists realized and planned dispositions by Georges Gemayel tied to option exercises.

The filing documents a 10,000-share sale on 03/05/2026 with proceeds of $537,117.00, plus reported exercises yielding 5,000 and 3,787 common shares on 03/04/2026 and 03/06/2026.

These entries follow Rule 144 notification practice; cash treatment is shown for the option exercises. Subsequent SEC filings or broker reports may provide settlement details.

Insider Transactions Specialist

Transactions combine past open‑market sales and option exercise distributions.

The record separates a completed sale (10,000 shares, $537,117.00) from shares listed as sold or to be sold following option exercises on 03/04/2026 and 03/06/2026. The filing notes a registered plan exercise as the source for some shares.

Timing and final disposition amounts are those listed; cash‑flow recipients are indicated by the cash entries next to each exercise date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 filed by Georges Gemayel disclose for SUPN?

The Form 144 disclosed a 10,000-share sale on 03/05/2026 for $537,117.00. It also lists 5,000 and 3,787 shares tied to option exercises on 03/04/2026 and 03/06/2026.

How many shares were sold in the past three months according to the filing?

The filing shows a past sale of 10,000 shares on 03/05/2026 with proceeds of $537,117.00. That entry is listed under "Securities Sold During The Past 3 Months."

Were any shares reported as resulting from option exercises in the Form 144?

Yes. The notice lists 5,000 shares from a previously exercised option on 03/04/2026 and 3,787 shares from an exercise under a registered plan on 03/06/2026, both marked as cash transactions.

Does the Form 144 state how the exercised shares will be sold?

The filing notes cash treatment and references an "Exercise of options under a registered plan" for the 3,787-share entry on 03/06/2026. Specific sales methods or brokers are not detailed in the provided excerpt.

Who appears as the reporting person on the Form 144 excerpt?

The excerpt identifies Georges Gemayel with an address in Rockville, MD, as the reporting person associated with the listed transactions and sales entries across the March 2026 dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001256088
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SUPERNUS PHARMACEUTICALS, INC.
SEC File Number	001-35518
Address of Issuer	9715 Key West Avenue Rockville MARYLAND 20850
Phone	301-838-2500
Name of Person for Whose Account the Securities are To Be Sold	GEORGES GEMAYEL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8787	465770.75	57581712	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/06/2026	Exercise of options under a registered plan	Issuer			3787	03/06/2026	Cash
Common	03/05/2026	Previously Exercised Options	Issuer			5000	03/04/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
GEORGES GEMAYEL 9715 Key West Avenue Rockville MD 20850	Common	03/05/2026	10000	537117.00

144: Remarks and Signature

Remarks
Date of Notice	03/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Georges Gemayel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)